BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6582521)

  • 41. Role of prostaglandins in regulation of erythroleukemic cell proliferation and differentiation.
    Santoro MG
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():395-9. PubMed ID: 2936130
    [No Abstract]   [Full Text] [Related]  

  • 42. Expression of red cell specific determinants during differentiation in the K562 erythroleukaemia cell line.
    Horton MA; Cedar SH; Edwards PA
    Scand J Haematol; 1981 Oct; 27(4):231-40. PubMed ID: 6180468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of erythroid differentiation in K562 cells and natural killer cell-mediated lysis: distinct effects at the level of recognition and lysis in relation to target cell proliferation.
    Hagner G
    Immunobiology; 1984 Oct; 167(4):389-97. PubMed ID: 6595216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythroid differentiation and commitment in rat erythroleukemia cells with hypertonic culture conditions.
    Yamaguchi Y; Kluge N; Ostertag W; Furusawa M
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2325-9. PubMed ID: 6941291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction.
    Villeval JL; Pelicci PG; Tabilio A; Titeux M; Henri A; Houesche F; Thomopoulos P; Vainchenker W; Garbaz M; Rochant H; Breton-Gorius J; Edwards PA; Testa U
    Exp Cell Res; 1983 Jul; 146(2):428-35. PubMed ID: 6575918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of myeloid-specific antigens on two human erythroleukaemia cell lines, HEL and K562.
    Rimmer EF; Horton MA
    Leuk Res; 1984; 8(2):207-11. PubMed ID: 6585603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
    Leuk Res; 1983; 7(4):481-5. PubMed ID: 6684716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythroid differentiation-inducing activity of protoporphyrin IX and its analogs on human leukemia K562 cell line.
    Nakajima O; Hashimoto Y; Iwasaki S
    Biochem Biophys Res Commun; 1994 Jan; 198(2):720-7. PubMed ID: 8297384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of apolipoprotein E expression during erythroid differentiation of human K562 leukemia cells.
    Crespo P; Delgado MD; Gómez-Casares MT; Cuadrado MA; Richard C; León J
    Leuk Res; 1993 Sep; 17(9):771-6. PubMed ID: 8371577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization and induction of a cell line established from a patient with erythroleukemia (FAB M6).
    Kambayashi H; Kawaguchi M; Abe R; Kimura H; Kariyone S
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):35-44. PubMed ID: 2330804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of spectrin in normal and malignant erythropoiesis.
    Ekblom M
    Scand J Haematol; 1984 Oct; 33(4):378-85. PubMed ID: 6594743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens.
    Leary JF; Ohlsson-Wilhelm BM; Giuliano R; LaBella S; Farley B; Rowley PT
    Leuk Res; 1987; 11(9):807-15. PubMed ID: 3478529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of erythroid differentiation in the human leukaemia cell line K562.
    Andersson LC; Jokinen M; Gahmberg CG
    Nature; 1979 Mar; 278(5702):364-5. PubMed ID: 570644
    [No Abstract]   [Full Text] [Related]  

  • 54. Human leukemia cell line K562 responds to erythroid-potentiating activity.
    Gauwerky CE; Lusis AJ; Golde DW
    Blood; 1982 Feb; 59(2):300-5. PubMed ID: 6976809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation of human erythroleukemia K562 cells without chemical inducer and the role of iron-saturated transferrin.
    Murate T; Kaneda T; Hotta T; Goto S
    Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1006-15. PubMed ID: 3201894
    [No Abstract]   [Full Text] [Related]  

  • 56. K562--a human leukemia cell line with erythroid features.
    Gahmberg CG; Andersson LC
    Semin Hematol; 1981 Jan; 18(1):72-7. PubMed ID: 7010612
    [No Abstract]   [Full Text] [Related]  

  • 57. Apigetrin induces erythroid differentiation of human leukemia cells K562: proteomics approach.
    Tsolmon S; Nakazaki E; Han J; Isoda H
    Mol Nutr Food Res; 2011 May; 55 Suppl 1():S93-S102. PubMed ID: 21480518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human acute myeloid leukemia lines: models of leukemogenesis.
    Koeffler HP
    Semin Hematol; 1986 Jul; 23(3):223-36. PubMed ID: 3092357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells.
    Amagasaki T; Green R; Jacobsen DW
    Blood; 1990 Oct; 76(7):1380-6. PubMed ID: 2169922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. K562 cell erythroid differentiation: requirement for a factor in fetal bovine serum.
    Hicks DG; Ohlsson-Wilhelm BM; Farley BA; Kosciolek BA; Rowley PT
    Exp Hematol; 1985 May; 13(4):273-80. PubMed ID: 3921391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.